About Olon Active Pharmaceutical Ingredients India Private Limited
Data last updated:
Olon Active Pharmaceutical Ingredients India Private Limited is a foreign private limited company based in Thane, Maharashtra, India, a subsidiary of Olon S.P.A. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2018FTC314115. Its GSTIN is 27AACCO7798Q1ZA (Maharashtra).
The company has an authorised share capital of ₹37.5 Cr and a paid-up capital of ₹37.5 Cr. It is led by directors including Marcellino Buson and Panchal Ambalal Natwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹431.21 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹107.36 Cr (net margin 24.9%) and EBITDA of ₹161.06 Cr (EBITDA margin 37.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.
The company has about 295 employees on its provident fund (EPFO) records.
The company has 1 deal on record (1 rights issue); the latest was in January 2019. Its 4 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Biophore India Pharmaceuticals Private Limited with revenue of ₹457 Cr. The company has 9 MSME Form 1 returns on record between 2020 and 2023, listing 367 overdue payments to 51 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website olonspa.com.
Company details
CIN history
Olon Active Pharmaceutical Ingredients India has one previous CIN (Corporate Identification Number): U36999MH2018FTC314115. The current CIN is U24100MH2018FTC314115, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2018FTC314115 | Current |
| U36999MH2018FTC314115 | Previous |
Contact details
Olon Active Pharmaceutical Ingredients India Private Limited's registered office is in Thane, Maharashtra. Its website is olonspa.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 2801A 28th Floor Plot No. D – 33 D207, Rupa Renaissance Juinagar MIDC Road Ttc Industrial Area, Thane, Maharashtra, India – 400705
- IndustryPharma, API Manufacturers
To see the full contact details of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Olon Active Pharmaceutical Ingredients India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Financials of Olon Active Pharmaceutical Ingredients India Private Limited
FY 2025 filings availableOlon Active Pharmaceutical Ingredients India Private Limited reported revenue of ₹431.21 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 11% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹161.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹107.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.4% | ||||
| Net Profit Margin | 24.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Board of directors of Olon Active Pharmaceutical Ingredients India Private Limited
Olon Active Pharmaceutical Ingredients India has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Marcellino Buson | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
| Panchal Ambalal Natwar | Director | 26 Apr 2024 | 2 Years 6 Months | Current |
| Luca Caironi | Director | 15 Oct 2018 | 8 Years 0 Months | Current |
| Mehul Kantilal Bhatt Also directs: Renew Sun Shakti Private Limited | Director | 19 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Olon Active Pharmaceutical Ingredients India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biophore India Pharmaceuticals Private Limited | ₹457 Cr (FY 2025) | 18.0% | Hyderabad, Telangana, India | |||
| S Kant Healthcare Limited | ₹452.24 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Olon Active Pharmaceutical Ingredients India Private Limitedthis company | ₹431.21 Cr (FY 2025) | ₹107.36 Cr | 24.9% | 11.0% | 295 | Thane, Maharashtra, India |
| Sterling Biotech Limited | ₹428.01 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Penam Laboratories Limited | ₹407.63 Cr (FY 2025) | -26.0% | New Delhi, Delhi, India |
To see the full peer comparison of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Auditor
Olon Active Pharmaceutical Ingredients India Private Limited is audited by R. U. Kamath & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. U. Kamath & Co. | FY 2023 | 104650W |
Shareholding
The shareholding of Olon Active Pharmaceutical Ingredients India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Deals & funding
Olon Active Pharmaceutical Ingredients India Private Limited has 1 deal on record (1 rights issue); the latest was in January 2019.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Rights issue | ₹37.49 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Olon Active Pharmaceutical Ingredients India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Olon Active Pharmaceutical Ingredients India Private Limited was last rated by Crisil on 31 Dec 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 31 Dec 2021 |
To see the full credit ratings and regulatory alerts of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
MSME payment delays
Olon Active Pharmaceutical Ingredients India Private Limited has 9 MSME Form 1 returns on record between 2020 and 2023, listing 367 overdue payments to 51 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 51)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sierra Instrumentation and Controls | |||
| an individual supplier | |||
| Bintex Corporates Private Limited | |||
| R.Stahl Private Limited | |||
| Vimta Labs Limited |
To see the full MSME payment records of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Olon Active Pharmaceutical Ingredients India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Employees & EPFO
Olon Active Pharmaceutical Ingredients India Private Limited has a workforce of 295 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Olon Active Pharmaceutical Ingredients India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCO7798Q1ZA | Maharashtra | Active | 12 Nov 2018 |
To see the full GST registrations and return filing status of Olon Active Pharmaceutical Ingredients India Private Limited, buy the company report.
Recent activity
Olon Active Pharmaceutical Ingredients India Private Limited has 12 board changes on record since 2018: 4 appointments and 8 cessations. The latest: Mehul Kantilal Bhatt ceased to be Additional Director on 26 Sep 2024.
3 earlier events are in the company report.
News
Frequently asked questions
Olon Active Pharmaceutical Ingredients India is an active foreign private limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 September 2018 (8+ years old) and is registered under CIN U24100MH2018FTC314115.
Olon Active Pharmaceutical Ingredients India has 4 current directors:
- Marcellino Buson - Director
- Panchal Ambalal Natwar - Director
- Luca Caironi - Director
- Mehul Kantilal Bhatt - Director
The latest financial statements of Olon Active Pharmaceutical Ingredients India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Olon Active Pharmaceutical Ingredients India is 27AACCO7798Q1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Olon Active Pharmaceutical Ingredients India is U24100MH2018FTC314115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olon Active Pharmaceutical Ingredients India was incorporated on 18 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Olon Active Pharmaceutical Ingredients India has 1 deal on record (1 rights issue); the latest was in January 2019.
The peers of Olon Active Pharmaceutical Ingredients India by revenue are Biophore India Pharmaceuticals Private Limited, S Kant Healthcare Limited, Sterling Biotech Limited, Penam Laboratories Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mehul Kantilal Bhatt ceased to be Additional Director on 26 Sep 2024. Panchal Ambalal Natwar was appointed as Director on 26 Apr 2024. Mehul Kantilal Bhatt was appointed as Director on 19 Jan 2024. Olon Active Pharmaceutical Ingredients India has 12 board changes on record in total.
Olon Active Pharmaceutical Ingredients India has 9 MSME Form 1 returns on record between 2020 and 2023, listing 367 overdue payments to 51 micro and small suppliers. The latest return was filed on 27 Feb 2024.
Olon Active Pharmaceutical Ingredients India can be reached through the website olonspa.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Olon Active Pharmaceutical Ingredients India is at Unit No. 2801A 28th Floor Plot No. D – 33 D207, Rupa Renaissance Juinagar MIDC Road Ttc Industrial Area, Thane, Maharashtra, India – 400705.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
